Use of health care services and pharmaceutical agents in coeliac disease: a prospective nationwide study
<p>Abstract</p> <p>Background</p> <p>Approximately 1% of the population suffer from coeliac disease. However, the disease is heavily underdiagnosed. Unexplained symptoms may lead to incremented medical consultations and productivity losses. The aim here was to estimate...
Main Authors: | Ukkola Anniina, Kurppa Kalle, Collin Pekka, Huhtala Heini, Forma Leena, Kekkonen Leila, Mäki Markku, Kaukinen Katri |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-09-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-230X/12/136 |
Similar Items
-
Small-intestinal TG2-specific plasma cells at different stages of coeliac disease
by: Minna Hietikko, et al.
Published: (2018-12-01) -
NEUROLOGIC MANIFESTATIONS IN COELIAC DISEASE PATIENTS
by: Y. A. DMITRIEVA, et al.
Published: (2017-07-01) -
Non-Responsive Coeliac Disease: A Comprehensive Review from the NHS England National Centre for Refractory Coeliac Disease
by: Hugo A. Penny, et al.
Published: (2020-01-01) -
The Long-Term Safety and Quality of Life Effects of Oats in Dermatitis Herpetiformis
by: Anna Alakoski, et al.
Published: (2020-04-01) -
Self-Reported Fractures in Dermatitis Herpetiformis Compared to Coeliac Disease
by: Camilla Pasternack, et al.
Published: (2018-03-01)